Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev Esp Quimioter ; 32 Suppl 2: 69-72, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31475815

RESUMO

The difference between demand and supply has led transplant organizations to look for marginal donors, including those who could transmit infections to their recipients. This potential risk must be thoroughly evaluated to optimize the use of such organs without increasing the incidence of graft dysfunction and the morbidity and mortality of the recipient. This article aims to provide a general and up-to-date overview of this issue.


Assuntos
Controle de Infecções/métodos , Transplante de Órgãos/efeitos adversos , Infecção da Ferida Cirúrgica/prevenção & controle , Doadores de Tecidos , Obtenção de Tecidos e Órgãos , Humanos , Incidência , Infecção da Ferida Cirúrgica/epidemiologia
6.
An Med Interna ; 19(1): 23-6, 2002 Jan.
Artigo em Espanhol | MEDLINE | ID: mdl-11989076

RESUMO

Campylobacter spp is not usual as the aetiology agent for spontaneous bacterial peritonitis. We report two cases of spontaneous peritonitis due to Campylobacter jejuni diagnosed in our hospital and review the literature trough MEDLINE data base. We found 13 cases of spontaneous peritonitis in which Campylobacter sp was isolated from ascitic fluid. The main characteristics of these cases were: the existence of an evolved alcoholic cirrhosis, a high positivity of blood cultures as well as a high relapse index and letality.


Assuntos
Infecções por Campylobacter/complicações , Cirrose Hepática/complicações , Peritonite/microbiologia , Humanos , Masculino , Pessoa de Meia-Idade
7.
An. med. interna (Madr., 1983) ; 19(1): 23-26, ene. 2002.
Artigo em Es | IBECS | ID: ibc-10440

RESUMO

Los microorganismos del género Campylobacter son infrecuentes como agente etiológico de la peritonitis bacteriana espontánea (PBE).Presentamos 2 casos de PBE por Campylobacter jejuni diagnosticados en nuestro hospital junto a una revisión de la literatura mediante el sistema MEDLINE. En total encontramos 13 casos de PBE en los que se aisló Campylobacter sp en el líquido ascítico. Las principales características de estos casos fueron: la existencia de una cirrosis hepática evolucionada de etiología enólica, una alta positividad de los hemocultivos así como un índice de recidiva y una letalidad elevada. (AU)


Assuntos
Pessoa de Meia-Idade , Masculino , Humanos , Peritonite , Infecções por Campylobacter , Cirrose Hepática
9.
Rev Clin Esp ; 200(4): 203-7, 2000 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-10857404

RESUMO

BACKGROUND: Anticoagulant therapy reduces the risk of stroke among patients with chronic atrial fibrillation. The objective of this study was to evaluate the use of anticoagulant therapy and to analyze the factors associated with the indication of anticoagulants in patients with chronic atrial fibrillation. PATIENTS AND METHODS: Prospective study of all patients with chronic atrial fibrillation admitted to our Department of Internal Medicine from February 1997 to September 1998. From each patient data related to the cause of atrial fibrillation, other associated vascular risk factors, use of anticoagulant and/or antiplatelet agents and contraindication to anticoagulants were recorded. RESULTS: A total of 170 patients with chronic atrial fibrillation were studied. The mean age of patients was 77 years (range: 49-94). One hundred and four patients (61%) were older than 75 years. Atrial fibrillation was the main cause for admission only in 11 patients (6.5%). One hundred and sixty-seven patients (98%) had indication for receiving anticoagulant therapy; however, it was indicated in only 67 patients (39%). In other 68 patients (40%), antiplatelet agents were used. Patients over 75 years received anticoagulants less frequently (p < 0.0001). Factors associated with the prescription of anticoagulants in the bivariate analysis included: diabetes mellitus (p = 0.046), high cholesterol level (p = 0.023), age < or = 75 years old (p < 0.0001), history of previous embolic events (p = 0.001) and valvular atrial fibrillation (p < 0.0001). The multivariate analysis showed that only two factors were indeed associated with the prescription of anticoagulants: age < or = 75 years (OR: 6.15) and valvular atrial fibrillation (OR: 4.24). CONCLUSIONS: Anticoagulant therapy is underused in patients with chronic atrial fibrillation, particularly in elderly patients.


Assuntos
Anticoagulantes/uso terapêutico , Fibrilação Atrial/complicações , Transtornos Cerebrovasculares/etiologia , Transtornos Cerebrovasculares/prevenção & controle , Inibidores da Agregação Plaquetária/uso terapêutico , Idoso , Idoso de 80 Anos ou mais , Doença Crônica , Prescrições de Medicamentos/estatística & dados numéricos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...